Coty Inc. is a global beauty company that specializes in the development, manufacturing, and marketing of a wide range of beauty products, including perfumes, cosmetics, and skincare solutions. With a diverse portfolio that includes both established and emerging brands, Coty aims to enhance the beauty experience for consumers through innovative and high-quality offerings. The company focuses on creating iconic fragrances, cutting-edge makeup products, and luxurious skincare treatments, catering to a variety of customer preferences and market segments. Through its commitment to sustainability and social responsibility, Coty continues to evolve its product lines and business practices to meet the changing needs of consumers around the world. Read More
Shares of beauty products company Coty (NYSE:COTY)
fell 10% in the afternoon session after the company reported mixed first quarter 2025 results which significantly beat analysts' EBITDA expectations, but revenue and EPS missed (though organic revenue beat). Organic sales in the Prestige segment dipped 2.5%, reflecting softer fragrance demand and a tough comparison from blockbuster launches last year, while Consumer Beauty sales fell 5% organically due to continued weakness in color cosmetics.
Zooming out, we think this was a decent quarter featuring some areas of strength but also some blemishes. The areas below expectations seem to be driving the move.
Coty Inc. (NYSE:COTY) shares dip premarket after Q3 FY25 results miss expectations. Sales fell 6.3% YoY to $1.30B, below the $1.31B estimate. LFL revenue dropped 3%, with declines across Prestige and Consumer Beauty. Gross profit slipped 7.3%, while adjusted EPS came in at $0.01 vs. $0.06 expected.
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET.
Beauty products company Coty (NYSE:COTY) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 6.2% year on year to $1.30 billion. Its non-GAAP profit of $0.01 per share was 81% below analysts’ consensus estimates.
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of Wednesday’s Federal Reserve meeting.
What has Wall Street been buzzing about this week? Here is a quick look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of April 14-17, 2025.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Olaplex (NASDAQ:OLPX) and the rest of the personal care stocks fared in Q4.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Nature's Sunshine (NASDAQ:NATR) and its peers.
Coty Inc. (NYSE: COTY) (Paris: COTY) ("Coty" or "the Company") one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, is proud to announce improvements in its Environmental, Social, and Governance (ESG) ratings from both MSCI and Sustainalytics.
Shares of beauty products company Coty (NYSE:COTY)
fell 9.3% in the afternoon session after Bank of America analysts issued a rare double downgrade on the company, shifting their rating from Buy to Sell, signaling a significant deterioration in their outlook. Alongside the downgrade, the firm slashed its price target from $9 to $4.50. The analysts pointed to declining market share, an indication the company was losing ground to competitors, and persistent softness in consumer spending, which could pressure both top-line growth and profitability.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including Nu Skin (NYSE:NUS) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care stocks fared in Q4, starting with Edgewell Personal Care (NYSE:EPC).
The past year hasn't been kind to the stocks featured in this article.
Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Inter Parfums (NASDAQ:IPAR) and the best and worst performers in the personal care industry.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at personal care stocks, starting with Medifast (NYSE:MED).
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Estée Lauder (NYSE:EL) and its peers.
